Sprycel (Dasatinib) — Patient Information (Australia)

Sprycel is the brand name for dasatinib, a medicine used to treat certain types of cancer caused by specific genetic changes. This page is written to help you understand what Sprycel does, how it works, how it is used in everyday life, and what to watch for. Always follow the advice of your treating healthcare professional and the directions on your medicine supply.

Basic product information

Important: Sprycel should be used only for the condition and dosing schedule agreed with your oncology team.

How Sprycel works (mechanism of action)

Dasatinib belongs to a class of medicines called tyrosine kinase inhibitors (TKIs). Many cancers—especially certain blood cancers—are driven by abnormal signalling proteins. In CML and Ph+ ALL, a major driver is the BCR-ABL fusion protein.

• Dasatinib blocks BCR-ABL activity, helping slow or stop the growth of cancer cells.
• It also affects other signalling pathways involved in cell growth and survival.
• Because it targets specific cellular signals, it is considered a targeted therapy, rather than a traditional chemotherapy approach.

Pharmacokinetics (how the body handles dasatinib)

Pharmacokinetics (PK) describes what happens to a medicine in the body—absorption, distribution, metabolism, and elimination.

• Absorption: Dasatinib is absorbed after oral dosing; food can reduce absorption depending on the meal type and timing.
• Peak levels: The medicine reaches highest blood concentrations a few hours after a dose (timing can vary between individuals).
• Distribution: It binds extensively to plasma proteins.
• Metabolism: Primarily metabolised in the liver, mainly via CYP3A4.
• Elimination: Metabolites are eliminated mostly through faeces; renal excretion is a smaller component.
• Drug interactions: Because metabolism involves CYP pathways, certain medicines can raise or lower dasatinib levels.

Why this matters: The way you take Sprycel (including food timing) and any interacting medicines (especially those affecting CYP3A4) can influence how well it works and how side effects present.

Typical use and common indications

Sprycel is used to treat specific blood cancers associated with the Philadelphia chromosome (Ph) and the BCR-ABL genetic change. Your specialist will determine suitability based on laboratory testing.

Common indications include

• Chronic Myeloid Leukaemia (CML):
  • Chronic phase CML with resistance or intolerance to prior therapy
  • Newly diagnosed Ph+ CML in certain treatment contexts (as per specialist assessment)
• Philadelphia chromosome–positive Acute Lymphoblastic Leukaemia (Ph+ ALL):
  • For adults and/or children depending on local treatment protocols and individual factors

Note: Indications and eligibility can vary based on country guidance, product information, and clinical circumstances. Your treating team will confirm the intended use for your situation.

Dosing overview and timing

Dosing can differ by the cancer type, disease phase, and prior treatments, and may be adjusted for tolerance, blood counts, and side effects.

How Sprycel is usually taken

• By mouth
• With or without food may be possible, but food timing is important (see the next section).
• Often taken once daily, but some regimens may use twice daily.

Missed dose

• If you miss a dose, follow your prescriber’s instructions.
• In general, do not take a double dose to make up for a missed one unless specifically instructed.

Practical timing tips

• Choose a daily time you can maintain consistently (e.g., morning with a routine).
• Set reminders for your dose schedule.
• If you are also taking other medicines, consider using a medication organiser to prevent mix-ups.

Do not change your dose or stop treatment without medical advice.

Food interactions and how to take Sprycel safely

Food can affect how much dasatinib your body absorbs. To reduce variability and support consistent exposure:

• Take Sprycel with consistency in relation to meals (either always with the same meal pattern your clinician recommends, or as directed on your medication instructions).
• Avoid taking it with certain heavy meals or immediately around meals if your product instructions advise a fasting period (your pharmacist can clarify the exact recommendation for your regimen).

Simple approach: If you’re unsure, ask your healthcare team for the specific instruction for your brand strength and schedule (because local guidance may vary).

Alcohol interactions

Alcohol does not have a single universal “safe” rule with dasatinib, because tolerance and liver function vary by person and treatment stage. However:

• Because dasatinib is processed by the liver, heavy or frequent alcohol intake may increase strain on the liver.
• Alcohol can also worsen side effects such as fatigue and nausea, making treatment harder to tolerate.

Practical advice: If you drink alcohol, discuss a safe amount with your oncology team. It’s often best to limit or avoid alcohol during active treatment, especially if you have abnormal liver blood tests or significant side effects.

Medicine interactions (including OTC medicines and supplements)

Dasatinib has meaningful drug interaction potential. Many interactions relate to liver enzymes (especially CYP3A4) and medicines that affect stomach acid or absorption.

Common interaction risks

• Strong CYP3A4 inhibitors can increase dasatinib blood levels, raising the risk of side effects.
• Strong CYP3A4 inducers can reduce dasatinib levels, potentially reducing effectiveness.
• Acid-reducing medicines (for example, proton pump inhibitors or H₂-blockers) may change stomach acidity and affect absorption.
• Other medicines that prolong the QT interval (some antiarrhythmics and certain antibiotics/antipsychotics) may increase the risk of rhythm problems.

What to do

• Tell your healthcare team about all medicines and supplements you take, including “natural” products.
• Before starting any new medication, ask your pharmacist if it can interact with dasatinib.
• Be cautious with OTC pain relievers: many are safe, but some combinations may affect bleeding risk depending on your condition and other therapies.

Do not start, stop, or change doses of interacting medicines without advice.

Safety profile: side effects to know about

Like all cancer medicines, Sprycel can cause side effects. Many are manageable, and your team can adjust dosing or provide supportive treatments. Still, some effects require prompt medical attention.

Common side effects

• Low blood counts (leading to infection risk, anaemia, or bleeding tendencies)
• Fluid retention or swelling (oedema)
• Fatigue
• Gastrointestinal effects such as nausea, diarrhoea, or constipation
• Muscle or joint aches
• Headache
• Rashes or skin changes

Serious but important potential risks

• Pleural effusion (fluid around the lungs) and breathing difficulties
• Serious infections due to low white blood cells
• Bleeding when platelets are low
• Heart rhythm changes (QT prolongation) or other cardiac effects
• Severe liver or kidney effects are less common but can occur—monitoring is important

Seek urgent medical help if you notice

• Trouble breathing, chest pain, or a sudden increase in shortness of breath
• Fainting, severe dizziness, or a very fast/irregular heartbeat
• Uncontrolled bleeding, black/tarry stools, or unusual bruising
• High fever or signs of serious infection (especially if blood counts are low)
• Severe or persistent vomiting or signs of dehydration

Practical use tips (everyday guidance)

• Keep a medication record: note dose times, missed doses, and any side effects. This helps your team make adjustments quickly.
• Attend regular blood tests: monitoring blood counts and organ function is essential to safety and effectiveness.
• Plan for infections: practise good hand hygiene and seek advice early if fever occurs.
• Hydration: drink enough fluids unless your clinician has restricted fluids.
• Skin care: moisturise regularly and protect skin from sun exposure if rashes occur.
• Report new symptoms promptly: early reporting improves management—especially breathing changes and swelling.

Handling the medicine safely at home

• Follow the tablet handling instructions from the pharmacy and product packaging.
• Keep the medicine out of reach of children and pets.
• Store at the recommended temperature and away from moisture and heat (as stated on the label).

Alternative options (discuss with your specialist)

There are several other therapies for Ph+ leukaemias and CML/ALL, depending on disease phase, prior treatments, and genetic resistance patterns. Alternatives may include other TKIs or different treatment strategies. Options commonly discussed with specialists may include:

• Other tyrosine kinase inhibitors (depending on availability and clinical appropriateness)
• Monoclonal antibodies or combination regimens for certain cases
• Chemotherapy or targeted approaches in specific scenarios
• Stem cell transplant may be considered in selected high-risk cases

Important: The “best” option depends strongly on your test results (e.g., mutation profiles), previous response, and your tolerance. Always speak with your treating team before changing therapy.

Recent guidance and monitoring (Australia)

In Australia, treatment decisions for CML and Ph+ ALL are typically guided by clinical protocols, specialist oncology review, and product information. Because recommendations may evolve with new evidence, it’s important to rely on your oncology team and current national resources.

In many centres, monitoring often includes:

• Regular full blood count to check for anaemia, neutropenia, and thrombocytopenia
• Assessment of disease response using specific blood tests and molecular monitoring (e.g., BCR-ABL transcript levels)
• Heart monitoring if you have risk factors or symptoms (for example, with electrocardiograms if indicated)
• Assessment for fluid-related symptoms such as breathlessness or swelling
• Liver function tests during treatment

Your clinician may adjust the dose schedule based on response and side effects. Always follow the latest advice provided by your treatment team.

Delivery and availability in Australia

Availability can vary depending on stock levels, dose strengths, and supply timing. In Australia, cancer medicines such as Sprycel may be supplied through specialist pharmacy networks and require appropriate dispensing processes.

• Online ordering: Some pharmacies offer online ordering for eligible items. Availability depends on current stock and logistics.
• Timeframes: Delivery times vary by location and courier service. For time-critical regimens, contact customer support to confirm dispatch and expected delivery.
• Cold chain: Sprycel does not typically require cold chain storage for standard tablet handling, but always follow the storage instructions on the packaging.

Tip: If you are starting a new cycle or have limited supply, order early and allow time for dispensing and delivery.

Market and legal context (Australia)

In Australia, medicines are regulated under the Therapeutic Goods framework. Cancer medicines are dispensed according to prescription and dispensing rules set by Australian health regulations. Your healthcare provider will determine the correct medicine and regimen for your condition, and pharmacies must follow relevant laws and professional standards.

Availability, subsidy arrangements, and dispensing requirements may differ depending on factors such as eligibility and the program under which you receive treatment. If you have questions about access, ask your pharmacist or treating team.

FAQ: Sprycel (dasatinib)

1) What is Sprycel used for?

Sprycel (dasatinib) is used to treat certain blood cancers associated with the Philadelphia chromosome (Ph+) and BCR-ABL genetic activity, such as chronic myeloid leukaemia (CML) and Philadelphia chromosome–positive acute lymphoblastic leukaemia (Ph+ ALL), based on specialist assessment.

2) How do I take Sprycel?

Take Sprycel by mouth exactly as directed. Dosing schedules can vary (commonly once daily, sometimes twice daily). Keep dosing times consistent and follow specific food instructions provided with your medicine.

3) Can I take Sprycel with food?

Food can affect absorption. Your prescriber or pharmacist will give specific instructions about whether to take it with meals or after a fasting period. The safest approach is to follow those instructions exactly and keep your routine consistent.

4) What if I miss a dose?

Follow the instructions provided by your healthcare team. In general, do not take an extra dose unless advised. If you’re unsure, contact your pharmacist.

5) What are the most important side effects to watch for?

Common side effects include fatigue, nausea, diarrhoea/constipation, rash, and changes in blood counts. Seek urgent medical advice for breathing difficulties, chest pain, fainting/severe dizziness, uncontrolled bleeding, or signs of serious infection such as fever.

6) Does Sprycel affect blood counts?

Yes. Sprycel can lower white blood cells, red blood cells, and platelets. Regular blood tests are essential, and you should seek medical advice early if you develop fever or unusual bruising or bleeding.

7) Are there medicines I should avoid?

Yes, some medicines can change dasatinib levels or increase risk of side effects, especially strong CYP3A4 inhibitors/inducers and certain medicines affecting heart rhythm or stomach acid. Always review your full medicine list with your pharmacist.

8) Can I drink alcohol while on Sprycel?

Alcohol is not universally “forbidden,” but it can increase liver strain and worsen symptoms such as fatigue or nausea. Discuss a safe approach with your oncology team—especially if your liver tests are abnormal.

9) How long does Sprycel take to work?

Response can vary. Some patients may show early improvement, while deeper molecular responses may take months. Ongoing monitoring (including blood and molecular tests) helps measure effectiveness over time.

10) Are there alternatives to Sprycel?

Yes. Depending on your specific diagnosis, disease phase, and mutation profile, specialists may consider other TKIs or different treatment regimens. Ask your treating team what options are appropriate for your case.

When to get help

If you experience severe or worsening symptoms, or you’re unsure whether something you feel could be related to Sprycel, contact your treating healthcare team promptly. For emergency symptoms such as severe breathlessness, chest pain, fainting, or uncontrolled bleeding, seek urgent medical assistance.

Reminder: This information is general and not a substitute for personalised medical advice. Your healthcare professional can provide guidance tailored to your condition, dose strength, and other medicines you take.